Li M - Search Results

1

Efficacy and safety of traditional Chinese medicinal enemas for treatment of chronic renal failure: A protocol for systematic review and meta-analysis.

Wu L, Wang Y, Liu Y, Wu L, Cheng D, Jiang T, Qu B, Lu H, Yang J, Tang A, Li M. Wu L, et al. Among authors: li m. Medicine (Baltimore). 2020 Oct 30;99(44):e23002. doi: 10.1097/MD.0000000000023002. Medicine (Baltimore). 2020. PMID: 33126381 Free PMC article.

2

A systematic review on the efficacy and safety of PA21 versus sevelamer in dialysis patients.

Xie D, Ye N, Li M. Xie D, et al. Among authors: li m. Int Urol Nephrol. 2018 May;50(5):905-909. doi: 10.1007/s11255-017-1774-9. Epub 2018 Jan 2. Int Urol Nephrol. 2018. PMID: 29294216 Review.

3

Is there a cardiovascular protective effect of aspirin in chronic kidney disease patients? A systematic review and meta-analysis.

Qu B, He Y, Wu L, Lu H, Wu H, Li M. Qu B, et al. Among authors: li m. Int Urol Nephrol. 2020 Feb;52(2):315-324. doi: 10.1007/s11255-019-02350-8. Epub 2019 Dec 9. Int Urol Nephrol. 2020. PMID: 31820360

4

[Establishment of animal model of ischemic acute kidney injury].

Wu L, Jiang T, Tang A, Zhao L, Li M. Wu L, et al. Among authors: li m. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Sep;32(9):1149-1152. doi: 10.3760/cma.j.cn121430-20200417-00309. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33081909 Chinese.

5

Shenshuaikang Enema, a Chinese Herbal Remedy, Inhibited Hypoxia and Reoxygenation-Induced Apoptosis in Renal Tubular Epithelial Cells by Inhibiting Oxidative Damage-Dependent JNK/Caspase-3 Signaling Pathways Using Network Pharmacology.

Lu H, Luo X, He Y, Qu B, Zhao L, Li M. Lu H, et al. Among authors: li m. Evid Based Complement Alternat Med. 2020 Nov 17;2020:9457101. doi: 10.1155/2020/9457101. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33281919 Free PMC article.

6

Effects of exercise on markers of inflammation and indicators of nutrition in patients with chronic kidney disease: a systematic review and meta-analysis.

Wu L, Liu Y, Wu L, Yang J, Jiang T, Li M. Wu L, et al. Among authors: li m. Int Urol Nephrol. 2022 Apr;54(4):815-826. doi: 10.1007/s11255-021-02949-w. Epub 2021 Jul 13. Int Urol Nephrol. 2022. PMID: 34255271 Review.

7

Madelung's disease with alcoholic liver disease and acute kidney injury: A case report.

Wu L, Jiang T, Zhang Y, Tang AQ, Wu LH, Liu Y, Li MQ, Zhao LB. Wu L, et al. World J Clin Cases. 2021 Sep 26;9(27):8199-8206. doi: 10.12998/wjcc.v9.i27.8199. World J Clin Cases. 2021. PMID: 34621881 Free PMC article.

8

Emodin-Mediated Treatment of Acute Kidney Injury.

Liu Y, Li M, Teh L, Zhao L, Ye N, Wu L, Wu L. Liu Y, et al. Among authors: li m. Evid Based Complement Alternat Med. 2022 Mar 21;2022:5699615. doi: 10.1155/2022/5699615. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35356249 Free PMC article. Review.

9

Klotho's impact on diabetic nephropathy and its emerging connection to diabetic retinopathy.

Tang A, Zhang Y, Wu L, Lin Y, Lv L, Zhao L, Xu B, Huang Y, Li M. Tang A, et al. Among authors: li m. Front Endocrinol (Lausanne). 2023 Apr 18;14:1180169. doi: 10.3389/fendo.2023.1180169. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37143722 Free PMC article. Review.

10

Emodin prevents renal ischemia-reperfusion injury via suppression of p53-mediated cell apoptosis based on network pharmacology.

Lu H, Xie D, Qu B, Li M, He Y, Liu W. Lu H, et al. Among authors: li m. Heliyon. 2023 Apr 22;9(5):e15682. doi: 10.1016/j.heliyon.2023.e15682. eCollection 2023 May. Heliyon. 2023. PMID: 37215853 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68,691 results

Search Page